Ticker: NYSE: UAMY | Company: United States Antimony Corporation | Category: Critical Minerals / Defense / Small-Cap
The Setup: A Tiny Company at the Center of a Major Geopolitical Crisis
If you haven’t heard of antimony, you’re not alone. But the Pentagon has. China has. And increasingly, investors are starting to pay attention.
United States Antimony Corporation (NYSE: UAMY) is a small-cap miner and smelter based in Montana that, until recently, was quietly processing one of the most obscure metals on the periodic table. Today, it holds a $248 million sole-source defense contract with the U.S. Defense Logistics Agency, a $27 million Defense Production Act grant, and the distinction of being the only fully integrated antimony producer in the free world outside of China and Russia.
That’s not a marketing claim. That’s just the reality of how concentrated this supply chain is — and why UAMY’s story matters.
What Is Antimony and Why Does the Defense Department Care?
Antimony is a silvery metalloid with a deceptively wide range of critical applications. On the civilian side, it’s used as a flame retardant in plastics and textiles, in lead-acid batteries, and in semiconductor diodes. On the defense side, it’s indispensable: antimony trisulfide is a key primer compound in ammunition, it appears in armor-piercing rounds, night vision goggle components, infrared sensors, precision optics, and bullet coatings.
In short: no antimony, no bullets. No night vision. Diminished missile guidance systems.
China produces an estimated 48–50% of the world’s mined antimony and controls an even larger share of global processing and refining. When China announced export restrictions on antimony in August 2024 — formally banning exports to the United States in December 2024 — it sent a shockwave through U.S. defense procurement circles. Antimony spot prices surged from roughly $5,000/metric ton pre-restriction to north of $29,000/metric ton by late 2024.
This is the same critical minerals export control playbook we saw play out in tungsten with Guardian Metal (GMTL), which IPO’d directly into a 557% price rally. Antimony followed a similar trajectory — and USAC was the only domestic processing option left standing.
The U.S. National Defense Stockpile, already being drawn down at an accelerated rate, suddenly looked dangerously thin. Enter USAC.
The Defense Contract: A 16x Revenue Multiplier in One Announcement
On September 22, 2025, the U.S. Defense Logistics Agency (DLA) Strategic Materials awarded USAC a sole-source, five-year IDIQ contract for antimony metal ingots at 99.65% purity. Maximum contract value: $248 million through September 2030.
The “sole-source” designation is critical. It means the DLA awarded this without competitive bidding — because USAC is the only domestic supplier capable of meeting the spec. The company operates North America’s only two active antimony smelters: its flagship Thompson Falls facility in Montana and its Mexican operations.
To contextualize: USAC’s total revenues for all of 2024 were $14.94 million. The DLA contract alone represents a 16x multiple of that figure — spread over five years but with guaranteed government purchase orders. Initial delivery orders in September 2025 and January 2026 totaled approximately $12 million.
A commercial supply agreement worth approximately $107 million brings total new contract backlog to $354 million.
The China Critical Minerals War: Context Investors Can’t Ignore
UAMY’s government windfall didn’t happen in a vacuum. It’s the direct result of a years-long escalation in the US-China critical minerals trade war.
The timeline:
- 2023: China restricts gallium, germanium, and rare earth processing technology exports
- August 2024: China announces antimony export licensing requirements; prices surge
- December 3, 2024: China formally bans antimony exports to the United States
- May 2025: Enforcement expands to tungsten and rare earths
- October 9, 2025: China announces sweeping new export controls on rare earths
- November 9, 2025: Following Trump-Xi summit, China suspends antimony ban until November 2026
The November 2025 “suspension” is worth examining carefully. China did not revoke the restrictions — it suspended them for one year following diplomatic negotiations. The metals remain on China’s dual-use export control list. The prohibition on exports to U.S. military users remains in full effect regardless. This is a temporary diplomatic pause, not a structural reversal.
As CSIS noted: “Antimony is a critical input for the defense industry, particularly for armor-piercing ammunition, night vision goggles, infrared sensors, bullets, and precision optics.” The underlying strategic problem — America’s dangerous dependence on China for a defense-critical mineral — hasn’t been solved by a diplomatic handshake.
That’s precisely why the DLA locked in a five-year sole-source contract with USAC before the ink was dry on the diplomatic agreement. The rare earth supply chain vulnerability extends well beyond antimony — we covered a similar dynamic in JAGU and Spartan Metals’ rare earth supply chain trade.
Company Overview: More Than Just Antimony
USAC isn’t a single-product company. Understanding its full operational footprint matters for evaluating both its upside potential and its complexity risks.
Core Operations:
- Montana (Thompson Falls): Primary antimony smelting facility. Expansion targeted to reach approximately 400–500 metric tons/month upon completion (targeted early April 2026). Also processes gold and silver from third-party ore.
- Mexico: Second smelting facility providing additional capacity and geographic diversification.
- Idaho (Bear River Zeolite): Zeolite mining and processing for water filtration, sewage treatment, nuclear waste cleanup, and agricultural markets.
Expansion Pipeline:
- Alaska: 35,000-acre land package comprising 120+ mining claims for domestic antimony extraction
- Ontario, Canada (Fostung Property): Engineering study valued inferred tungsten resources at over $4.6 billion — long-term optionality on critical minerals diversification
- Additional antimony and cobalt claims in Montana
Financials: The Numbers Behind the Story
| Metric | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $39.26M | $14.94M | +163% |
| Gross Profit | $9.87M | $3.47M | +185% |
| Gross Margin | 25% | 23% | +2pts |
| Net Loss | ($4.34M) | ($1.73M) | Wider |
| Cash + Investments | $91.3M | $18.2M | +401% |
| Working Capital | $44.6M | $16.7M | +167% |
| Long-term Debt | ~$195K | — | Minimal |
Revenue growth was primarily driven by antimony segment performance: antimony revenues surged 219% to $35.4 million in 2025, with approximately 230% of that growth attributable to average selling price per pound. This is the China export ban effect in full display — prices outside China went parabolic, and USAC was one of the only Western suppliers who could capture it.
The cash build is the headline on the balance sheet. The company entered 2025 with $18.2 million in cash. It exited 2025 with $91.3 million in cash, U.S. Treasuries, and equity securities — raised through $36.7M in ATM offerings, $67.6M from three direct offerings with institutional investors, and $5.7M from warrant exercises ($104M+ total).
The caveat: That capital raise came with significant dilution. The $4.34M net loss was largely driven by $6.7M in non-cash stock compensation. Management is spending aggressively on building out its critical minerals platform — which looks smart strategically but creates near-term EPS headwinds.
Forward Guidance:
- FY2025 actual: $39.26M (consistent with prior guidance of $40–43M)
- FY2026 guidance: $125 million — a 3x jump as DLA contract deliveries ramp
- Analysts project 2026 FCF of approximately $3.95M, scaling to $76M by 2030
Valuation: The Bull and Bear Cases
Current Market Snapshot (as of March 2026):
- Share price: ~$9.50–$9.70
- Market cap: ~$1.33–1.40 billion
- Wall Street consensus: 4 Buy ratings, median price target $11.00 (range $10.25–$13.50)
Bull Case
If USAC delivers on $125M in FY2026 revenue as guided, the current price-to-sales multiple compresses dramatically. At a P/S of 5x (still premium to mining peers given the critical defense angle), you get a rough implied valuation of ~$625M — below current. At higher multiples justified by government contract visibility and strategic monopoly positioning, bulls can argue for $12–15+.
The strategic moat argument is real: sole-source government contractor + only fully integrated domestic producer + government capital behind expansion = defensible competitive position.
Bear Case
At 30–40x trailing revenue, UAMY is priced for perfection. The $248M DLA contract is IDIQ — it sets a ceiling, not a floor. Actual delivery orders depend on government procurement cadence, and the first $12M in orders represents only about 5% of the contract maximum.
Additional risks:
- Dilution history: $104M in equity raised in 2025 alone; further dilution possible as capex needs persist
- Execution risk: Montana facility expansion must hit capacity targets; delays hurt near-term delivery capability
- Antimony price sensitivity: ~230% of 2025 revenue growth was price-driven — if antimony prices normalize, the financial story weakens quickly
- Geopolitical whipsaw: The November 2025 China trade truce temporarily softened urgency; further diplomatic easing could reduce government priority on the DLA contract
- Small-cap volatility: The stock has traded between roughly $1.78 (early 2025) and over $11
The $27M DPA Grant: Government Putting Skin in the Game
On March 5, 2026, USAC was awarded $27 million under Title III of the Defense Production Act from the Department of Defense.
DPA Title III awards are specifically designed to fund domestic industrial base expansion for defense-critical supply chains. This isn’t a commercial contract — it’s a federal investment in USAC’s infrastructure. The funds will support:
- Expansion and modernization of the Montana smelting facility
- Development of Alaskan extraction operations (the 35,000-acre land package)
- Full vertical integration from mine to finished antimony product
The fact that the U.S. government is simultaneously buying USAC’s product and funding the expansion of its capacity is a powerful signal of strategic commitment. It’s not a relationship that ends with a single contract renewal cycle.
Competitive Positioning: The Only Game in Town
USAC’s competitive moat can be summarized in one sentence: there is no viable domestic alternative.
The U.S. has no other fully integrated antimony miner-processor. Other Western nations have limited primary production. Tajikistan has emerged as a secondary global supplier, but processing and refining capabilities outside China are thin. Bolivia, Australia, and parts of Europe have exploration-stage projects, but building a mine and smelter from scratch takes 5–10 years and hundreds of millions in capital.
For U.S. defense planners who cannot source from China — or whose Chinese-sourced material is now explicitly banned for military end-uses regardless of any diplomatic truce — USAC is the only realistic option at scale within U.S. borders.
This is why the DLA issued a sole-source contract without competitive bidding. Because there was no competition.
The Verdict: Legitimate Thesis, But Priced for Execution
UAMY is not a lottery ticket. It’s a real company with real government contracts, real infrastructure, and real strategic relevance at a moment when the U.S.-China critical minerals conflict is structurally reshaping defense supply chains.
The bull thesis is simple and coherent: the only domestic antimony processor + $248M DLA contract + $27M DPA grant + $125M FY2026 revenue guide + no meaningful debt = a legitimate critical minerals growth story.
The risk is in the valuation and execution. At $1.3–1.4 billion market cap against $39M in trailing revenue, you’re paying a steep premium for what is still a pre-ramp story. The DLA contract deliveries are just beginning. The Montana expansion isn’t yet complete. The $125M FY2026 target is ambitious.
The honest framing for investors: UAMY is a genuine strategic play on a genuine geopolitical problem — but it’s already priced to reflect a lot of that future. The question isn’t whether the antimony supply chain matters to U.S. defense. It clearly does. The question is whether current shareholders get paid while management executes the ramp.
Position sizing accordingly. Watch Q1 and Q2 2026 delivery order volumes under the DLA contract as the key near-term inflection point. If those numbers confirm a serious ramp, the $11–13 analyst targets start looking achievable. If deliveries lag or antimony prices soften further, the multiple compression could be painful.
- Risk Level: HIGH-MEDIUM (speculative growth with genuine strategic backing)
- Time Horizon: 12–24 months to validate the $125M revenue guide
- Catalysts to watch: Q1 2026 earnings, DLA delivery order announcements, Montana facility completion, antimony spot price movements
This article is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results. Always do your own due diligence before making investment decisions. Critical minerals markets are highly volatile and subject to geopolitical risks outside any company’s control. The author may hold positions in securities mentioned.